InvestorsHub Logo
icon url

dewophile

08/04/24 10:00 AM

#3052 RE: biocqr #3051

Thanks
The pan-coronavirus potential of the drug is emphasized in this paper, something Enanta has never really leaned into in any presentation to investors
PS: some small bios would have released a PR when data is published, although this is just preclinical and ENTA management was never one to put out a bunch of frivolous PRs (they even decided 3 months ago not to hold a cc with tomorrow's earnings release so they are very much in a we will wait until we have something meaningful to say mode)